Bioxyne Limited (BXN) is an Australian life science, health and medical technology company involved in the development, manufacture and distribution of nutritional supplements and beauty products through wholesale and direct sales channels. The Group has a global distribution agreement with Denmark's Chr Hansen to manufacture, market, supply and distribute its proprietary probiotic strain of Lactobacillus Fermentum PCC for over the counter dietary supplement products.
Bioxyne
Follow
Get notifications in MyBN when activity occurs.
Company Activity
NEWS: Tagged in Anti-hero: Share prices rise high on antimony finds | 23 Aug 2024 | |
NEW ROLE: Samuel Watson, Chief Executive Officer, Managing Director | 11 Jul 2024 | |
NEW ROLE: Jason Hine, Non-Executive Director | 11 Jul 2024 | |
NEWS: Tagged in Kula share price gets warmer with new gold sting | 09 Feb 2024 | |
NEW ROLE: NH Chua, | 08 Jan 2024 | |
REMUNERATION UPDATE: Tony Ho, Non-Executive Chair | 13 Nov 2020 | |
REMUNERATION UPDATE: Nam H Chua, Chief Executive Officer, Managing Director | 13 Nov 2020 | |
REMUNERATION UPDATE: Peter C Hughes-Hallett, Non-Executive Director | 13 Nov 2020 | |
REMUNERATION UPDATE: Patrick Ford, Non-Executive Director | 13 Nov 2020 |